Cargando…
Tectorigenin Inhibits Glioblastoma Proliferation by G0/G1 Cell Cycle Arrest
Background and objectives: Glioblastoma is one of the leading cancer-related causes of death of the brain region and has an average 5-year survival rate of less than 5%. The aim of this study was to investigate the effectiveness of tectorigenin, a naturally occurring flavonoid compound with anti-inf...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763962/ https://www.ncbi.nlm.nih.gov/pubmed/33321738 http://dx.doi.org/10.3390/medicina56120681 |